Literature DB >> 28549061

Central hypothyroidism - a neglected thyroid disorder.

Paolo Beck-Peccoz1, Giulia Rodari2, Claudia Giavoli2, Andrea Lania3.   

Abstract

Central hypothyroidism is a rare and heterogeneous disorder that is characterized by a defect in thyroid hormone secretion in an otherwise normal thyroid gland due to insufficient stimulation by TSH. The disease results from the abnormal function of the pituitary gland, the hypothalamus, or both. Moreover, central hypothyroidism can be isolated or combined with other pituitary hormone deficiencies, which are mostly acquired and are rarely congenital. The clinical manifestations of central hypothyroidism are usually milder than those observed in primary hypothyroidism. Obtaining a positive diagnosis for central hypothyroidism can be difficult from both a clinical and a biochemical perspective. The diagnosis of central hypothyroidism is based on low circulating levels of free T4 in the presence of low to normal TSH concentrations. The correct diagnosis of both acquired (also termed sporadic) and congenital (also termed genetic) central hypothyroidism can be hindered by methodological interference in free T4 or TSH measurements; routine utilization of total T4 or T3 measurements; concurrent systemic illness that is characterized by low levels of free T4 and normal TSH concentrations; the use of the sole TSH-reflex strategy, which is the measurement of the sole level of TSH, without free T4, if levels of TSH are in the normal range; and the diagnosis of congenital hypothyroidism based on TSH analysis without the concomitant measurement of serum levels of T4. In this Review, we discuss current knowledge of the causes of central hypothyroidism, emphasizing possible pitfalls in the diagnosis and treatment of this disorder.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28549061     DOI: 10.1038/nrendo.2017.47

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  131 in total

1.  Congenital central hypothyroidism due to a homozygous mutation in the thyrotropin beta-subunit gene follows an autosomal recessive inheritance.

Authors:  B M Doeker; R W Pfäffle; J Pohlenz; W Andler
Journal:  J Clin Endocrinol Metab       Date:  1998-05       Impact factor: 5.958

Review 2.  Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism.

Authors:  Wilmar M Wiersinga
Journal:  Nat Rev Endocrinol       Date:  2014-01-14       Impact factor: 43.330

3.  Neonatal screening for congenital hypothyroidism based on thyroxine, thyrotropin, and thyroxine-binding globulin measurement: potentials and pitfalls.

Authors:  M J E Kempers; C I Lanting; A F J van Heijst; A S P van Trotsenburg; B M Wiedijk; J J M de Vijlder; T Vulsma
Journal:  J Clin Endocrinol Metab       Date:  2006-06-20       Impact factor: 5.958

4.  Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism.

Authors:  E Ferretti; L Persani; M L Jaffrain-Rea; S Giambona; G Tamburrano; P Beck-Peccoz
Journal:  J Clin Endocrinol Metab       Date:  1999-03       Impact factor: 5.958

5.  Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. Effect of treatment with thyrotropin-releasing hormone.

Authors:  P Beck-Peccoz; S Amr; M M Menezes-Ferreira; G Faglia; B D Weintraub
Journal:  N Engl J Med       Date:  1985-04-25       Impact factor: 91.245

Review 6.  Newborn screening strategies for congenital hypothyroidism: an update.

Authors:  Stephen H LaFranchi
Journal:  J Inherit Metab Dis       Date:  2010-03-02       Impact factor: 4.982

7.  Congenital isolated central hypothyroidism caused by a "hot spot" mutation in the thyrotropin-beta gene.

Authors:  Michael T McDermott; Bryan R Haugen; Jennifer N Black; William M Wood; David F Gordon; E Chester Ridgway
Journal:  Thyroid       Date:  2002-12       Impact factor: 6.568

8.  Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.

Authors:  Maria Rita Gamberini; Vincenzo De Sanctis; Giuseppe Gilli
Journal:  Pediatr Endocrinol Rev       Date:  2008-10

9.  Changes in the degree of sialylation of carbohydrate chains modify the biological properties of circulating thyrotropin isoforms in various physiological and pathological states.

Authors:  L Persani; S Borgato; R Romoli; C Asteria; A Pizzocaro; P Beck-Peccoz
Journal:  J Clin Endocrinol Metab       Date:  1998-07       Impact factor: 5.958

10.  Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling.

Authors:  M Harris; C Aschkenasi; C F Elias; A Chandrankunnel; E A Nillni; C Bjøorbaek; J K Elmquist; J S Flier; A N Hollenberg
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

View more
  26 in total

1.  Mammosomatotroph and mixed somatotroph-lactotroph adenoma in acromegaly: a retrospective study with long-term follow-up.

Authors:  Liang Lv; Yong Jiang; Senlin Yin; Yu Hu; Cheng Chen; Weichao Ma; Shu Jiang; Peizhi Zhou
Journal:  Endocrine       Date:  2019-07-31       Impact factor: 3.633

Review 2.  Interactions between hypothalamic pituitary thyroid axis and other pituitary dysfunctions.

Authors:  Ulla Feldt-Rasmussen; Marianne Klose; Salvatore Benvenga
Journal:  Endocrine       Date:  2018-09-06       Impact factor: 3.633

3.  Phenytoin- Medication That Warrants Deviation From Standard Approach for Thyroid Lab Interpretation.

Authors:  Vishwanath Pattan; Narsimha Candula; Ramesh Adhikari; Rahul Kashyap
Journal:  Cureus       Date:  2020-11-04

4.  Interpreting Elevated TSH in Older Adults.

Authors:  Jennifer S Mammen
Journal:  Curr Opin Endocr Metab Res       Date:  2019-04-25

Review 5.  Hypothyroidism.

Authors:  Layal Chaker; Salman Razvi; Isabela M Bensenor; Fereidoun Azizi; Elizabeth N Pearce; Robin P Peeters
Journal:  Nat Rev Dis Primers       Date:  2022-05-19       Impact factor: 52.329

6.  The extant immunoglobulin superfamily, member 1 gene results from an ancestral gene duplication in eutherian mammals.

Authors:  Courtney L Smith; Paul M Harrison; Daniel J Bernard
Journal:  PLoS One       Date:  2022-06-02       Impact factor: 3.752

Review 7.  Thyroid hormone and the brain: Mechanisms of action in development and role in protection and promotion of recovery after brain injury.

Authors:  Yan-Yun Liu; Gregory A Brent
Journal:  Pharmacol Ther       Date:  2018-02-09       Impact factor: 12.310

Review 8.  Recent Advances in Thyroid Hormone Regulation: Toward a New Paradigm for Optimal Diagnosis and Treatment.

Authors:  Rudolf Hoermann; John E M Midgley; Rolf Larisch; Johannes W Dietrich
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-22       Impact factor: 5.555

9.  2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism.

Authors:  Luca Persani; Georg Brabant; Mehul Dattani; Marco Bonomi; Ulla Feldt-Rasmussen; Eric Fliers; Annette Gruters; Dominique Maiter; Nadia Schoenmakers; A S Paul van Trotsenburg
Journal:  Eur Thyroid J       Date:  2018-07-19

10.  Immune Checkpoint Inhibitors-Related Thyroid Dysfunction: Epidemiology, Clinical Presentation, Possible Pathogenesis, and Management.

Authors:  Ling Zhan; Hong-Fang Feng; Han-Qing Liu; Lian-Tao Guo; Chuang Chen; Xiao-Li Yao; Sheng-Rong Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-10       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.